ClinConnect ClinConnect Logo
Search / Trial NCT03664050

Laparoscopic Ovarian Drilling Versus Letrozole In Clomiphene Citrate Resistant Polycystic Ovary

Launched by AIN SHAMS UNIVERSITY · Sep 7, 2018

Trial Information

Current as of July 05, 2025

Unknown status

Keywords

Letrozol Laparoscopic Ovarian Drilling

ClinConnect Summary

No description provided

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. patients diagnosed as PCOS according to Roterdam (2003) criteria
  • 2. patients with Clomiphene resistance, i.e. failure to ovulate following 100 mg CC for 5 days for at least three cycles.
  • 3. patent fallopian tubes, confirmed by hysterosalpingography or hysteroscopic diagnosis.
  • 4. normal semen analysis parameters of the patients' spouses according to the modified criteria of the World Health Organization.
  • 5. normal serum prolactin, thyroid stimulating hormone and 17-OH progesterone.
  • 6. no systemic disease; no gonadotropin or other hormonal drug treatment during the preceding 3 months.
  • Exclusion Criteria:
  • 1- Infertility induced by reasons other than PCOS. 2- uterine cavity lesions or ovarian cyst. 3- \>40 years old. 4- body mass index (BMI) \>26 kg/m2. 5- contraindications to general anesthesia. 6- history of pelvic surgery. 7- other endocrine diseases. 8- a history of liver or kidney disease.
  • -

About Ain Shams University

Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.

Locations

Cairo, , Egypt

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials